Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
2.470
+0.010 (0.40%)
Aug 5, 2025, 4:25 PM CET
0.40%
Market Cap871.88M
Revenue (ttm)n/a
Net Income (ttm)-42.21M
Shares Out352.99M
EPS (ttm)-0.18
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume611,875
Average Volume800,015
Open2.500
Previous Close2.470
Day's Range2.470 - 2.500
52-Week Range0.956 - 4.990
Beta-0.14
RSI47.16
Earnings DateAug 29, 2025

About Ligand Pharmaceuticals

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.